Cloud Peak Energy (CLD) Misses Q1 EPS by 3c
Get Alerts CLD Hot Sheet
Join SI Premium – FREE
Cloud Peak Energy (NYSE: CLD) reported Q1 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $216.3 million versus the consensus estimate of $237.98 million.
2018 Guidance – Financial and Operational Estimates
“First quarter shipments declined compared to last year as utilities reduced their coal stockpiles. Customers are taking their contracted volumes, and we expect to sell our remaining open 2018 volumes during the year. International markets remain strong and interest for our Spring Creek product remains high. Our logistics export partners have been moving our contracted volumes, leaving us on track to export 5.5 million tons in 2018,” commented Marshall.
The following table provides the current outlook and assumptions for selected 2018 consolidated financial and operational metrics:
| Estimate or Estimated Range | |||||||||
| Coal shipments for the three mines(1) | 52 – 56 million tons | ||||||||
| Committed sales with fixed prices | Approximately 47 million tons | ||||||||
| Anticipated realized price of produced coal with fixed prices | Approximately $12.28 per ton | ||||||||
| Adjusted EBITDA(2) | $75 – $100 million | ||||||||
| Net interest expense | Approximately $37 million | ||||||||
| Cash interest paid | Approximately $42 million | ||||||||
| Depreciation, depletion, amortization, and accretion | $75 – $85 million | ||||||||
| Capital expenditures | $15 – $25 million | ||||||||
For earnings history and earnings-related data on Cloud Peak Energy (CLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share